Skip to content

Long GnRH agonist versus short agonist versus antagonist protocol in normal responders undergoing in vitro fertilization: a prospective randomized controlled trial

Long GnRH agonist versus short agonist versus antagonist protocol in normal responders undergoing in vitro fertilization: a prospective randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008220
Enrollment
Unknown
Registered
2016-04-05
Start date
2016-04-04
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

A:GnRH short agonist
B:long GnRH agonist
C:GnRH antagonist

Sponsors

ReproductiveMedicine Center, Tongji Hospital, TongjiMedicine College, Huazhong University of Science and Technology,Wuhan, People's Republic of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. female age <40 years;normal menstrual cycles of 25–34 days,BMI 18-28kg/m2,basic FSH<10IU/L,1.0<AMH<3.5ng/ml; 2. Cause of infertility:tubal or male factor; 3. AFC7-20; 4. Normal uterine morphology.

Exclusion criteria

Exclusion criteria: PCOS,PCO,poor ovarian response, hydrosalpinx,endometriotic cyst, adenomyosishyperprolactinemia, CAH, thyroid disease, progesterone level on hCG day=1.5ng/ml, top quality embryos number<2.

Design outcomes

Primary

MeasureTime frame
live birth rate;

Secondary

MeasureTime frame
ongoing pregnancy rate;implantation rate;miscarriage rate;OHSS rates;No. of oocytes retrieved;No. of top quality embryos obtained;Blastocyst progression rate;

Countries

China

Contacts

Public ContactXu Bei

ReproductiveMedicine Center, Tongji Hospital, TongjiMedicine College, Huazhong University of Science and Technology

bei_bei81@126.com+86 13659863501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 18, 2026